Biogen Idec Achieves Positive Interim Results In Treating Early Stage Alzheimer's Patients

The company's BIIB037 shows promise for achieving the holy grail of Alzheimer treatment: reducing sticky plaque in the brain.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.